GSE133683 1 V 5 DOXORUBICIN MOUSE UP (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE133683 1 V 5 DOXORUBICIN MOUSE UP.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE133683 1 V 5 DOXORUBICIN MOUSE UP.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE133683 1 V 5 DOXORUBICIN MOUSE UP.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE133683 1 V 5 DOXORUBICIN MOUSE UP.

Results found

Linked to

 

Label

Description

 

Gene

RAD52 motif containing 1

Gene

cytokine receptor like factor 2

Gene

family with sequence similarity 174 member C

Gene

cytochrome c oxidase copper chaperone COX17

Gene

coiled-coil domain containing 112

Gene

transmembrane protein 9

Gene

CXXC repeat containing interactor of PDZ3 domain

Gene

signal peptidase complex subunit 1

Gene

transmembrane protein 218

Gene

PRELI domain containing 1

  • Gene

    RAD52 motif containing 1


  • Gene

    cytokine receptor like factor 2


  • Gene

    family with sequence similarity 174 member C


  • Gene

    cytochrome c oxidase copper chaperone COX17


  • Gene

    coiled-coil domain containing 112


  • Gene

    transmembrane protein 9


  • Gene

    CXXC repeat containing interactor of PDZ3 domain


  • Gene

    signal peptidase complex subunit 1


  • Gene

    transmembrane protein 218


  • Gene

    PRELI domain containing 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.